Original news and analysis on international IP policy
[Note: Monday midday update below] By William New Member governments of the World Health Organization will try this week to finalise a strategy and plan of action to stimulate innovation on diseases disproportionately affecting poor populations. The members also will…
By Liza Porteus Viana for Intellectual Property Watch Despite an apparent stalemate on patent reform in the United States Congress, the Bush administration is still pushing for a bill to be completed this congressional session. Speaking in California’s Silicon Valley…
By David Cronin for Intellectual Property Watch BRUSSELS – The European Parliament looks set to take Brussels’ top trade official to task over his latest attempt to persuade Thailand that it should revise its policy on pharmaceutical patents. Shortly after…
By William New India and other proponents on Wednesday sought to counter concern raised by the World Trade Organization chief that a “clash” could occur if differences are not narrowed on a proposed amendment to WTO intellectual property rules for…
Note: The latest version of the draft strategy (dated Saturday, 3 May, 14.00h) is now available on the WHO website [click here]. By Kaitlin Mara and William New The World Health Organization (WHO) negotiations on public health, intellectual property and…
By Kaitlin Mara and William New Members of the World Health Organization (WHO) gathered this week to address innovation and intellectual property issues in public health saw hope for agreement on a strategy paper focused on the needs of developing…
Kaitlin Mara Il est aussi important que compliqué d’avoir accès à des données de qualité sur les politiques menées en matière de propriété intellectuelle appliquée aux sciences de la vie. Telle est la conclusion d’une récente réunion d’experts techniques relative…
Por Kaitlin Mara Tener acceso a datos de calidad en el contexto de la reglamentación de la propiedad intelectual en el ámbito de las biociencias es una cuestión tan necesaria como difícil, según se dijo en una reunión de expertos…
By Claudia Jurberg for Intellectual Property Watch The Brazilian government recently declared the drug Tenofovir, used against HIV/AIDS, to be of public interest. The announcement signals the country’s interest in using an option to avoid the patent on the drug…
By Kaitlin Mara Access to quality data in intellectual property policy in the life sciences is as necessary as it is hard to obtain, said a recent meeting of technical experts, called to discuss challenges in patents and innovation in…
By Kaitlin Mara Intellectual property rights issues on the table in the newly invigorated World Trade Organization negotiations are at risk if remaining deep differences cannot be further narrowed in the coming weeks, WTO Director General Pascal Lamy said Thursday.…
By Catherine Saez After an innovative partnership between a non-governmental group and a pharmaceutical company led to a new cheap non-patented drug against malaria being available in Africa in 2007, the model is being implemented again with another new non-patented…